1 of 2
Story summary
- Trump's 39% tariff on Switzerland has led UBS to reduce its 2026 economic growth forecast to 0.9%.
- Switzerland significantly invests in the US, employing 407,000 Americans through its subsidiaries.
- The US administration may impose tariffs on pharmaceuticals, potentially prompting concessions from Swiss firms.
- UBS reported a 49% profit increase amid uncertainties related to US tariffs.
- Analysts caution that negative interest rates could harm Swiss banking profitability and economic stability.
1 / 2
